The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Early tumor shrinkage (eTS) as a predictive and prognostic factor in metastatic renal cell carcinoma (mRCC).

Viktor  Gruenwald

Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pfizer

Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MOLOGEN; MSD; Novartis; Pfizer

Speakers' Bureau - Novartis

Research Funding - AVEO (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)

Travel, Accommodations, Expenses - GlaxoSmithKline; MSD; Novartis; Pfizer

Xun  Lin

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Daniel  Kalanovic

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Ronit  Simantov

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer